CLINICAL STAGE III ESOPHAGEAL ADENOCARCINOMA AJCC V8
Clinical trials for CLINICAL STAGE III ESOPHAGEAL ADENOCARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE III ESOPHAGEAL ADENOCARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE III ESOPHAGEAL ADENOCARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat cancers? early trial combines three drugs
Disease control Not yet recruitingThis early-phase trial tests a new three-drug combination for people with advanced stomach, gastroesophageal junction, or esophageal cancer that cannot be removed by surgery. The study will enroll 18 participants to find the safest dose of futibatinib when given with standard che…
Matched conditions: CLINICAL STAGE III ESOPHAGEAL ADENOCARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 12, 2026 12:06 UTC
-
Remote workouts may help cancer survivors reclaim strength
Symptom relief Not yet recruitingThis study tests a personalized, supervised exercise program done at home to help people who finished treatment for gastroesophageal cancer improve their physical function. About 20 adults who completed chemotherapy or immunotherapy within the past year and have trouble with dail…
Matched conditions: CLINICAL STAGE III ESOPHAGEAL ADENOCARCINOMA AJCC V8
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 16, 2026 22:51 UTC
-
New study tracks physical decline during cancer treatment
Knowledge-focused Not yet recruitingThis study will follow 72 adults with early-stage gastroesophageal cancer to see how their physical function changes during chemotherapy. Participants will have their physical abilities measured at several points over six months. The goal is to understand which patients are at ri…
Matched conditions: CLINICAL STAGE III ESOPHAGEAL ADENOCARCINOMA AJCC V8
Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:08 UTC